General Information
Nilotinib, the active ingredient of nilotinib , belongs to the class of molecules termed antineoplastic agents, which inhibit the maturation, growth or spread of tumor cells. It is used for the treatment of chronic myeloid leukemia (CML) in patients exhibiting an abnormal chromosome called the Philadelphia chromosome.
About the API
Systematic name
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, monohydrochloride, monohydrate
Trade name(s)
Tasigna
Technology
Synthetic
Molecular Formula
C28H22F3N7O•HCl•H2O
Molecular Weight
584 g/mol
Therapeutic category
Oncology
Available formulations
Oral Solid